Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Reena Salgia, MD, Henry Ford Health System
home
Articles
HCC: Applying Recent Data Into Practice
July 13th 2020
HCC: Emerging Therapies Under Investigation
July 13th 2020
Combination Regimens for HCC Treatment
July 13th 2020
Emerging Biomarkers in Hepatocellular Carcinoma
July 13th 2020
HCC: Liver Function and Treatment Decisions
July 13th 2020
Safety Profiles of Novel Therapies for HCC
July 13th 2020
Sequencing of Novel Therapies in HCC
July 13th 2020
Regorafenib or Cabozantinib for Second-Line HCC
July 13th 2020
Selecting Second-Line Therapy for HCC
July 13th 2020
Second-Line Treatment for Hepatocellular Carcinoma
July 13th 2020
Novel Combinations to Treat HCC
July 13th 2020
Immunotherapy in Liver Cancer
July 13th 2020
HCC: Treating Patients With Atezolizumab/Bevacizumab
July 13th 2020
IO and VEGF Inhibition in Hepatocellular Carcinoma
July 13th 2020
Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma
July 13th 2020
Locoregional and Systemic Therapy for HCC
July 13th 2020
Hepatocellular Carcinoma: Diagnostic Work-Up
July 13th 2020
Surveillance for Hepatocellular Carcinoma
July 13th 2020
Incidence of Liver Cancer in the US
July 13th 2020